Complement-mediated neutralisation identified in ebola virus disease survivor plasma: implications for protection and pathogenesis

HIGHLIGHTS

  • who: Jack Mellors from the Department of Research and Evaluation, United Kingdom (UK) Health Security Agency, Salisbury, United Kingdom, Department of Infection Biology, Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom have published the research: Complement-Mediated Neutralisation Identified in Ebola Virus Disease Survivor Plasma: Implications for Protection and Pathogenesis, in the Journal: (JOURNAL)
  • what: The methods used in this study have previously been utilised and published for detecting antibody-dependent C3c deposition on the SARS-CoV-2 spike_protein and used again in a current preprint . Selection of Low-Neutralising Plasma . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?